Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Huahai Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Cash Flow Reinvestment Rate of 1.47x as of September 2025, reinvesting CN¥414.56 Million (capex CN¥414.56 Million ) from operating cash flow of CN¥282.81 Million. See Zhejiang Huahai Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Cash flow reinvestment rate of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. Historical reinvestment intensity for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Explore how well can Zhejiang Huahai Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Zhejiang Huahai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2001–2025)
Zhejiang Huahai Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2001 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Huahai Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Huahai Pharmaceutical Co Ltd cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.67x | CN¥2.05 Billion | CN¥1.23 Billion | CN¥1.97 Billion | ▲ +88.5% |
| 2024 | 0.89x | CN¥1.93 Billion | CN¥2.17 Billion | CN¥1.85 Billion | ▼ -38.9% |
| 2023 | 1.45x | CN¥3.22 Billion | CN¥2.22 Billion | CN¥1.59 Billion | ▼ -62.1% |
| 2022 | 3.82x | CN¥4.75 Billion | CN¥1.24 Billion | CN¥2.32 Billion | ▲ +43.9% |
| 2021 | 2.66x | CN¥2.49 Billion | CN¥938.43 Million | CN¥2.43 Billion | ▲ +197.2% |
| 2020 | 0.89x | CN¥1.39 Billion | CN¥1.56 Billion | CN¥1.28 Billion | ▲ +95.6% |
| 2019 | 0.46x | CN¥801.28 Million | CN¥1.75 Billion | CN¥794.31 Million | ▼ -97.5% |
| 2018 | 18.56x | CN¥1.26 Billion | CN¥67.90 Million | CN¥1.12 Billion | ▲ +787.1% |
| 2017 | 2.09x | CN¥1.14 Billion | CN¥546.24 Million | CN¥794.54 Million | ▲ +21.5% |
| 2016 | 1.72x | CN¥746.05 Million | CN¥433.10 Million | CN¥732.88 Million | ▼ -52.3% |
| 2015 | 3.61x | CN¥705.17 Million | CN¥195.31 Million | CN¥524.28 Million | ▲ +171.5% |
| 2014 | 1.33x | CN¥437.06 Million | CN¥328.61 Million | CN¥437.06 Million | ▲ +39.9% |
| 2013 | 0.95x | CN¥466.24 Million | CN¥490.29 Million | CN¥466.24 Million | ▼ -48.2% |
| 2012 | 1.84x | CN¥447.81 Million | CN¥243.83 Million | CN¥447.81 Million | ▲ +4.8% |
| 2011 | 1.75x | CN¥346.06 Million | CN¥197.51 Million | CN¥346.06 Million | ▲ +92.6% |
| 2010 | 0.91x | CN¥272.44 Million | CN¥299.47 Million | CN¥272.44 Million | ▲ +120.8% |
| 2009 | 0.41x | CN¥130.81 Million | CN¥317.44 Million | CN¥130.81 Million | ▼ -75.0% |
| 2008 | 1.65x | CN¥138.89 Million | CN¥84.20 Million | CN¥138.89 Million | ▲ +86.8% |
| 2007 | 0.88x | CN¥120.54 Million | CN¥136.52 Million | CN¥120.54 Million | ▼ -50.5% |
| 2006 | 1.78x | CN¥138.27 Million | CN¥77.54 Million | CN¥138.27 Million | ▼ -61.9% |
| 2005 | 4.67x | CN¥249.14 Million | CN¥53.30 Million | CN¥249.14 Million | ▲ +540.6% |
| 2004 | 0.73x | CN¥119.47 Million | CN¥163.73 Million | CN¥119.47 Million | ▼ -26.6% |
| 2003 | 0.99x | CN¥47.13 Million | CN¥47.41 Million | CN¥47.13 Million | ▲ +54.1% |
| 2002 | 0.65x | CN¥48.60 Million | CN¥75.34 Million | CN¥48.60 Million | ▼ -33.1% |
| 2001 | 0.96x | CN¥36.14 Million | CN¥37.51 Million | CN¥36.14 Million | — |